India and China their biggest target market!
MUMBAI: The Carlyle Group, the Washington-headquartered private equity firm, has reaffirmed its commitment to Asia by raising a third venture capital fund for the region.
Called the Carlyle Asia Growth Partners Fund, it has already collected $450 million under the fund, which is expected to close in early April.
Meanwhile, Carlyle Asia Growth Capital, a division of the Carlyle Group which invests primarily for significant minority stakes in growth stage companies in Asia, announced that it has invested $20 million in 5-year-old Claris Lifesciences, an unlisted pharmaceutical company that manufactures and markets products for treating critical illnesses. It takes the group’s total capital invested in India to little under $100 million, according to Shankar Narayanan, managing director and head of Carlyle’s India Growth Capital team.
snip...
Though Korea and Japan are other markets that have been on Carlyle’s radar, China and India make up about 70% of its total capital invested through venture and growth capital funds, said Narayanan.
more...
http://dnaindia.com/report.asp?NewsID=1019307